Drug Maker Probed After Baby Deaths12-24 00:00 财经网
BEIJING - China has sent health experts to investigate a drug maker to see if the deaths of several babies in recent weeks were related to vaccines they received in a government immunization program.
China Central Television said Tuesday that a team of government investigators had been sent to Biokangtai, a drug maker based in the southern city of Shenzhen.
The company's hepatitis B vaccines have come under scrutiny since authorities suspended their use for liver disease after the first deaths of babies were reported.
|Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine produced by the Shenzhen-based BioKangtai company. (screenshot from CCTV13)|
Provincial and national health authorities have separately reported that since November about a half-dozen babies died shortly after they received hepatitis B vaccines made by Biokangtai.
One case has been ruled out as being caused by the vaccine while the others were still being investigated.
The article was first published on China Daily.
Editors’ Picks »
- 1China to Cut Reserve Ratio for Some Rural Banks
- 2China M2 up 12.1Pc, Outstanding Yuan Loans 13.9 Pc in March
- 3Delayed Response to Tainted Water Raises Concerns
- 4China's FDI Inflow down 1.47% in March
- 5China's MMG to Acquire Las Bambas
- 6China’s Rare Earth Exchange Begins Trading Following WTO Ruling
- 7Alibaba’s Q4 Net Income More than Doubles Ahead of IPO
- 8China Trade Fair Shadowed by Weak Exports
- 9Embassy Says 2 Chinese Nationals Aboard Capsized S.Korean Ship
- 10South Korean Ferry Sinks off South Coast